von Minckwitz, G; du Bois, A; Schmidt, M et al.
Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a German breast group 26/breast international group 03-05 studyJ Clin Oncol. Bd. 27. 2008 S. 1999-2006
Hermes, M; Schormann, W; Brulport, M et al.
Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model.Br J Cancer. Bd. 98. H. 9. 2008 S. 1525-32
Holtmann, MH; Gerts, AL; Weinman, A et al.
Treatment of Crohn's disease with leflunomide as second-line immunosuppression : a phase 1 open-label trial on efficacy, tolerability and safety.Dig Dis Sci. Bd. 53. H. 4. 2008 S. 1025-32
Vehreschild, JJ; Bohme, A; Reichert, D et al.
Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole.Int J Hematol. Bd. 87. H. 2. 2008 S. 126-31
Möhler, M; Ridwelski, K; Karthaus, M et al.
Treatment of nonresectable liver metastasesOnkologie. Bd. 31. H. 5. 2008 S. 14-8
Bork, K; Staubach, P; Hardt, J
Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedemaAllergy. Bd. 63. H. 6. 2008 S. 751-757
Holfeld, J; Gottardi, R; Zimpfer, D et al.
Treatment of symptomatic coral reef aorta by endovascular stent-graft placementAnn Thorac Surg. Bd. 85. H. 5. 2008 S. 1817-19
Leeuwenburgh, SCG; Malda, J; Rouwkema, J et al.
Trends in biomaterials research: an analysis of the scientific program of the World Biomaterials Congress 2008Biomaterials. Bd. 29. 2008 S. 3047-3052
Bargou, R; Leo, E; Zugmaier, G et al.
Tumor regression in cancer patients by very low doses of a T cell-engaging antibody.Science. Bd. 321. H. 5891. 2008 S. 974-7
Knuf, M; Schmitt, HJ; Steul, K et al.
Two versus three doses of a meningococcal C conjugate vaccine concomitantly administered with a hexavalent DTaP-IPV-HBV/Hib vaccine in healthy infantsVaccine. Bd. 26. H. 18. 2008 S. 2242-2252